Literature DB >> 17437105

Regional CBF changes in Parkinson's disease: the importance of functional neuroimaging analyses.

Bárbara J Amorim, Erica C S Camargo, Elba C S C Etchebehere.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17437105     DOI： 10.1007/s00259-007-0411-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.

Authors:  Tommy Bosman; Koen Van Laere; Patrick Santens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-25       Impact factor: 9.236

2.  Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.

Authors:  Andrew Feigin; Angelo Antonini; Masafumi Fukuda; Roberta De Notaris; Riccardo Benti; Gianni Pezzoli; Marc J Mentis; James R Moeller; David Eidelberg
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

Review 3.  The diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Gregor Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

4.  Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease.

Authors:  A Antonini; R De Notaris; R Benti; D De Gaspari; G Pezzoli
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

5.  Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.

Authors:  Yasunori Mito; Kazuto Yoshida; Ichiro Yabe; Kenichi Makino; Makoto Hirotani; Kunio Tashiro; Seiji Kikuchi; Hidenao Sasaki
Journal:  Clin Neurol Neurosurg       Date:  2005-01-19       Impact factor: 1.876

6.  Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.

Authors:  Mirosława Derejko; Jarosław Sławek; Dariusz Wieczorek; Bogna Brockhuis; Mirosława Dubaniewicz; Piotr Lass
Journal:  Nucl Med Commun       Date:  2006-12       Impact factor: 1.690

7.  Regional cerebral blood flow in Parkinson's disease with and without dementia.

Authors:  M J Firbank; S J Colloby; D J Burn; I G McKeith; J T O'Brien
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

8.  HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.

Authors:  H S Markus; D C Costa; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

9.  SPECT findings in Parkinson's disease associated with dementia.

Authors:  H Sawada; F Udaka; M Kameyama; N Seriu; K Nishinaka; K Shindou; M Kodama; N Nishitani; K Okumiya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

10.  Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.

Authors:  R S Liu; K N Lin; S J Wang; D E Shan; J L Fuh; S H Yeh; H C Liu
Journal:  Nucl Med Commun       Date:  1992-10       Impact factor: 1.690
View more
  1 in total

Review 1.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.